Abstract IL-i is a family of polypeptides which play a critical role in the inflammatory response. Characteristics of this response include an enhanced release of bone marrow neutrophils, activation of circulating and tissue-phase phagocytes, and enhanced production of neutrophils and monocytes. We have sought to understand the hematopoietic response to acute and chronic inflammatory states on a cellular and molecular level. Colonystimulating factors (CSFs) are glycoproteins involved in the production and activation of neutrophils and monocytes in vitro and in vivo. We have found that quiescent dermal fibroblasts constitutively release granulocyte-macrophage CSF (GM-CSF), granulocyte CSF (G-CSF), and macrophage CSF in culture, and that picomolar concentrations of the inflammatory mediator IL-1 stimulate by at least fivefold the transcription and release of GM-CSF and G-CSF. These findings establish the role of IL-1 in the hematopoietic response to inflammation through the stimulation of the production and release of GM-CSF and G-CSF.
Introduction
Colony-stimulating factors (CSFs)' are acidic glycoproteins required for the survival, proliferation, and differentiation of hematopoietic progenitors in semi-solid medium. Four human CSFs have been characterized-granulocyte-macrophage CSF (GM-CSF), granulocyte CSF (G-CSF), macrophage CSF (M-CSF or CSF-1), and multi-CSF or IL-3 (for review, see reference 1)-which differ in progenitor cell specificity and physicochemical properties. Originally recognized on the basis of their effects in vitro, GM-CSF, G-CSF, and multi-CSF have been reported to stimulate in vivo hematopoiesis as well (2) (3) (4) , making these molecules likely physiologic regulators of blood cell production. Culture medium conditioned by several different tissues will support the growth of 1. Abbreviations used in this paper: BFU-E, erythroid burst-forming unit; CSF, colony-stimulating factor; G, granulocyte; GM, granulocyte-macrophage; M, macrophage, PHA-LCM, PHA-stimulated lymphocyte-conditioned medium; CFU-Meg, megakaryocytic CFU; CFUJ-Mix, mixed CFU. hematopoietic progenitor cells. When stimulated, fibroblasts, endothelial cells, smooth muscle cells, and lymphocytes secrete CSAs, making these cells candidate sources of hematopoietic growth factors in the marrow microenvironment.
Our understanding ofthe cells oforigin ofthe CSFs and the details of the regulation of production of the various CSFs is incomplete, but a recent model suggests that soluble products of monocytes play a central role. Bagby et al. have reported that monocyte-conditioned medium stimulates the production and release of CSAs from fibroblasts (5) , endothelial cells (6) , and lymphocytes (7) . This CSA(s) has the capacity to stimulate the growth of GM, G, megakaryocytic, and mixed-cell colonies as well as erythroid bursts. IL-I is a family of related polypeptides produced primarily by monocytes and which is a key mediator of the host response to infectious, inflammatory, and immunologic challenges. At least two polypeptides possessing IL-1 activity (IL-la and IL-I#) have been identified and cloned (8) . T lymphocytes, B lymphocytes, fibroblasts, endothelial cells, hepatocytes, neutrophils, and myocytes can be stimulated by IL-1 to generate many features of the inflammatory reaction (for review, see references 9 and 10). The effects of acute and chronic inflammation on the hematopoietic system include release of neutrophils from the vascular marginal pool, premature release of neutrophils from the marrow into the circulation, enhanced neutrophil chemotaxis to, and activation at, sites of inflammation, and a sustained increase in neutrophil and monocyte production. Many of these responses are evoked by the various CSFs in vitro.
We are interested in the molecular basis for the effects of IL-1 on hematopoiesis and cells of the marrow microenvironment. In this report, we present the results of studies of the effect of IL-1 on quiescent human dermal fibroblasts. When stimulated by picomolar concentrations of purified recombinant human IL-1, fibroblasts elaborate multiple CSAs into the surrounding medium. The release of these CSAs coincides within a fivefold increase of GM-CSF and G-CSF transcripts in the cytoplasm of the cells, and the appearance of GM-CSF and G-CSF in the culture medium.
Methods
Cell culture. Tenth-passage human dermal fibroblasts (kindly provided by Elaine Raines) were cultured in RPMI 1640 medium (Gibco, Grand Island, NY), supplemented with 10% FCS (HyClone, Inc., Logan, UT), penicillin (100 U/ml), streptomycin (100 gg/ml), and nystatin (25 ng/ml), and grown to confluence. Fresh medium containing 2% platelet-poor plasma was added, and the cells incubated for 48 h (quiescent cultures). Finally, medium containing 10-1,000 pg/ml (10 pg. 1 U) of purified recombinant human IL-la (Genzyme Corp., Boston, MA) was added, and the cells were cultured for 6-24 h. To prepare mitogen-stimulated lymphocytes and their conditioned media, peripheral blood mononuclear cells were cultured at 1 X 106 cells/ml in a-medium containing 10% FCS, antibiotics, and 1% PHA. Spent cul-ture medium was collected after 7 d (1 1). To prepare a positive CSA control for murine colony-forming cells, the murine splenic lymphoma cell line LBRM (kindly provided by S. Gillis) was grown in the presence of 1% PHA for 24 h and the medium collected.
Marrow colony-forming cell assays. Human marrow cells were obtained from normal volunteers with their informed consent, and fractionated on a Ficoll-Hypaque density gradient (1.077 g/ml; Litton Bionetics, Inc.). Low density cells were depleted of adherent cells by double-plastic adherence and of T cells by E rosetting (7) . The nonadherent, T-depleted cells (5 X 104/ml) were plated in a-medium (Gibco) containing 10% FCS, antibiotics, 0.1-10% by volume ofthe material to be assayed and the cultures were made semi-solid with 1% methylcellulose (Dow). Cultures were grown for 13 d in a humidified atmosphere containing 5% Co2, and colonies were enumerated with an inverted microscope. 50 U of GM-CSA is defined by the dilution that stimulates half-maximal colony formation, compared with an optimal concentration of PHA-stimulated lymphocyte-conditioned medium (PHA-LCG) as a control. For the growth of megakaryocytic colonies (from megakaryocytic CFU [CFU-Meg]), 25% human plasma was used instead of FCS ( 11) and, for the growth of erythroid bursts (from erythroid burst-forming units [BFU-E]) and mixed erythroid-nonerythroid colonies (from mixed CFU [CFU-Mix]), 1 U ofpurified recombinant human erythropoietin (AMGen, Inc., Thousand Oaks, CA) was added to cultures on day 4 (12) .
For murine granulocytic colony growth, LA/Fj mice were killed by cervical dislocation and femoral bone marrow obtained. 1 X 101 cells were plated in a-medium with 10% FCS, antibiotics, I -10% by volume of the conditioned medium to be assayed, and 0.3% agar. Cultures were incubated for 5 d. Whole l-ml cultures were fixed and stained for chloroacetate esterase and counterstained with toluidine blue. Pure granulocytic colonies were enumerated by direct microscopy. 50 U of G-CSA were defined as for GM-GSA, except comparison was to an optimal concentration of PHA-stimulated LBRM-conditioned medium.
Nucleic acidprobes. Anti-sense oligonucleotides, 40 bases in length and corresponding to bases 755 to 794 of the human GM-CSF gene (13) , bases 151 to 190 ofa human G-CSFcDNA (14) , bases 232 to 271 of a human M-CSF cDNA (15), and bases 73 to 112 of the human multi-CSF gene (16) were synthesized by the phosphotriester method (model 380A; Applied Biosystems Inc., Foster City, CA). The oligonucleotides were purified by polyacrylamide gel electrophoresis and end labeled with [9y2PJATP and polynucleotide kinase (2-4 X 108 cpm/,g sp act). These probes were specific for their respective growth factors as they contain no significant sequence homology and bind exclusively to appropriately sized transcripts in cells or cell lines producing M-CSF (MiaPaCa [15]), G-CSF (5637 [17] ), GM-CSF (5637 [18] ), or multi-CSF (PHA-stimulated lymphocytes [16] ). Full-length cDNAs for human GM-CSF (19) or for human G-CSF were nick-translated to high specific activity (1-4 X 108 cpm/.g) (20) and boiled before use.
RNA preparation andanalysis. Quiescent or IL-l -stimulated fibroblasts were rinsed in PBS and lysed with 5 M guanidium thiocyanate (21). RNA was recovered from a 5.7 M CsCl step gradient and resuspended in diethylpyrocarbonate-treated water. Samples were enriched for poly A-containing RNA by chromatography over oligo (dT) cellulose (22) . Aliquots were denatured with formamide and formaldehyde and size-fractionated by electrophoresis through 1.4% agarose-formaldehyde gels (23) . The RNA was transferred to nitrocellulose, prehybridized at 42°C for 4-6 h in SX SSC (1X SSC = 0.15 mM NaCl/15 mM Na citrate, pH 7.0), 2X Denhardt's, 50 mM Na phosphate, pH 7.0, 20% formamide, 10% dextran sulfate, 1 mM Na pyrophosphate, 50 ug/ml ATP, and 50 ug/ml sonicated salmon sperm DNA (24) .
Twenty-million counts per minute of probe were added to 10 ml of prehybridization solution and the blot was hybridized at 42°C for 12-16 h. For oligonucleotide probes, the blots were washed sequentially in 2X SSC/0.1% NaDodSO4 at 20°C, 40°C, and 65°C and prepared for autoradiography. For hybridization to the cDNA probes, the blots were hybridized as above except for the presence of 50% formamide, and were washed sequentially in 0.2X SSC/0. 1% NaDodSO4 at 20'C, 40'C, and 650C. The blots were probed sequentially with the M-CSF, GM-CSF, G-CSF, and the multi-CSF probes. Bound probe was removed by washing in water at 950C for 20 min between each hybridization.
Anti-GM-CSF antiserum and Western blot analysis. A 15 amino acid peptide that contains 13 residues near the carboxyl terminus of human GM-CSF (ESFKENLKDFLLV) was crosslinked to keyhole limpet hemocyanin, emulsified with complete Freund's adjuvant, and used to immunize NZY rabbits. After three booster immunizations using incomplete adjuvant, high anti-peptide antibody titers were detected. GM-CSF was found to react with this antiserum on Western blots when the protein was denatured and reduced in situ (19) . Proteins found to be nonreacting included insulin, transferrin, recombinant human G-CSF (AMGen, Inc.), recombinant platelet-derived growth factor (Zymogenetics, Inc., Seattle, WA), and recombinant human M-CSF (Cetus, Inc., Emeryville, CA). However, several high molecular weight plasma proteins crossreacted with this antiserum when the Western blot was handled as described. Fibroblast-conditioned media containing 2% platelet-poor plasma were concentrated 30-fold by ultrafiltration (Amicon PM-10), reduced by boiling in 0.5 M fl-mercaptoethanol and 0.5% NaDodSO4, and I0-,ul aliquots were size-fractionated by electrophoresis through 15% polyacrylamide gels. Proteins were transferred to nitrocellulose by electroblotting (25) and were reduced on the blot as described (19) . The Western blot was probed with a 1:200 dilution of antiserum and with a 1:1,000 dilution of 1251I-goat anti-rabbit IgG antiserum.
Results
Fibroblast-derived CSA. As shown in Table I , the culture medium conditioned by quiescent, confluent fibroblasts supports low level growth of hematopoietic progenitor cells in semisolid culture. By dose-response analysis, a mean of 150 U/ml of CSA was detected in six separate experiments. In contrast, the addition ofIL-la at concentrations from 10 to 1,000 pg/ml greatly enhanced the release of CSAs into the medium. As shown, IL-la at 100 pg/ml resulted in the maximal amount of CSA detected at 24 h. IL-la alone at 10-100 pg/ml had a negligible effect on GM colony growth and no effect on erythroid burst or megakaryocyte colony growth (data not shown). Next, the time course of CSA induction was studied using 100 pg/ml IL-la. Within 6 h ofthe addition of IL-la to quiescent, confluent fibroblasts, elevated levels of CSA were detectable in the culture medium. CSA continued to accumulate in the medium up to 24 h of culture.
To assess the ability of the fibroblast-derived growth factor(s) to stimulate in vitro erythropoiesis and megakaryopoiesis, assays for BFU-E, CFU-Meg, and CFU-Mix were performed. In addition to their stimulation of GM colonies, the CSAs released by IL-la-stimulated fibroblasts support the growth of erythroid bursts, mixed erythroid-nonerythroid colonies, and megakaryocytic colonies. As shown in Fig. 1 , stimulation of erythroid bursts occurred at all dilutions of conditioned medium that stimulated GM colony growth. In addition, a near-maximal number of mixed-cell colonies, and approximately half-maximal numbers of megakaryocytic colonies developed, compared with an optimal concentration of PHA-LCM.
RNA analysis. To determine the molecular basis of the apparent multiple CSAs elaborated by IL-la-stimulated fibroblasts, RNA was extracted from these cells and from quiescent fibroblasts, and probed for the presence of known hematopoietic growth factor mRNA. Oligonucleotides complementary to the 5' end of human multi-CSF, GM-CSF, G-CSF, or M-CSF mRNA were prepared and used to probe Northern blots of fibroblast RNA.
The Northern blot pattern of poly A RNA derived from cells known to produce M-CSF is complex, but growth conditions known to stimulate the production of M-CSF are associated with the presence of three to six hybridizing bands ( 15). Three hybridizing bands were seen in quiescent fibroblast RNA when the blot was probed for M-CSF-specific mRNA (Fig. 2) .
A clear, low intensity signal was seen when unstimulated fibroblast RNA was probed for GM-CSF and for G-CSF-specific message. However, no signal was seen when the blot was hybridized with a probe for human multi-CSF (data not shown). When stimulated with IL-la (100 pg/ml) for 8 h, strong signals for GM-CSF and G-CSF were seen. The signals seen with the GM-CSF and G-CSF oligonucleotide probes were confirmed with full-length cDNA probes (data not shown). The signal for M-CSF-specific RNA was little changed from that seen in unstimulated fibroblast RNA. Again, no signal for human multi-CSF was detected. After autoradiography with the cDNA probes, and after rehybridization with the M-CSF probe, the hybridizing bands were cut from the blot and counted directly for (3-emissions. Five times more GM-CSF or G-CSF probe hybridize with 5 ,ug of IL-l a-stimulated fibroblast poly A RNA than with the same amount of unstimulated fibroblast poly A RNA. The bands hybridizing to the M-CSF probe contained nearly the same amount of labeled probe.
Detection ofspecific CSFs in conditioned media. To detect human M-CSF, conditioned media were analyzed by radioimmunoassay (26) . Medium conditioned by quiescent fibroblasts contained 119 U/ml of M-CSF. IL-la-stimulated fibroblastconditioned medium contained 155 U/ml M-CSF. These levels are significantly above the detectable level (2 25 U/ml), but are not significantly different (error not greater than 20%).
To detect human G-CSF (17), cultures of murine bone marrow stimulated with fibroblast-conditioned medium were evaluated by cytochemical techniques for neutrophilic colonies. Human multi-CSF and human GM-CSF fail to stimulate the growth of murine CFU-GM-derived colonies. Although human M-CSF is a potent stimulus of murine CFU-M, few, if any, ofthe resultant colonies are purely neutrophilic. Thus, the growth of murine neutrophilic colonies in response to human fibroblast-conditioned medium suggests either the presence of an as yet undescribed hemopoietin or, more likely, the presence of human G-CSF. As shown in Table II , quiescent fibroblast-conditioned medium supports the growth of a small number of murine neutrophilic colonies. When compared with a standard source of recombinant human G-CSF, 280 U/ml of G-CSF was detected. When stimulated with IL-la, fibroblasts release increased quantities ofG-CSF into their me- Dilutions of quiescent and IL-la-stimulated fibroblast-conditioned medium (FCM) were plated in a murine colony assay. Only pure neutrophil colonies (chloroacetate esterase positive) were enumerated. Culture medium from the murine cell line LBRM stimulated with PHA served as a positive control, and purified recombinant human G-CSF (AMGen, Inc.) and recombinant human GM-CSF were used to demonstrate the specificity of the assay. The results represent the mean±SEM of four separate experiments. FCM0 represents medium conditioned by unstimulated fibroblasts; FCMIJ1 represents the medium conditioned by IL-la-stimulated fibroblasts.
dium. When quantitated by dose-response analysis, 3,040 U/ml were detected. Finally, to detect human GM-CSF protein, we used a rabbit antiserum raised against a human GM-CSF peptide to probe Western blots of fibroblast-conditioned medium. As shown in Fig. 3 , GM-CSF was undetectable in 30-fold concentrated conditioned medium from quiescent fibroblasts. The lower limit of detection by this assay is 400 U. Clear signals for glycosylated and nonglycosolated GM-CSF are present in 30-fold concentrated IL-la-stimulated fibroblastconditioned medium. 
Discussion
Fibroblasts are cells that have diverse functions. They provide the scaffolding required for cellular organization, maintain the extracellular matrix required for tissue cohesion, and may function as antigen-presenting cells (27) (28) (29) . Fibroblasts are present in the bone marrow, and have been postulated to function as part of an inductive microenvironment (30, 31) . Fibroblasts are also effector cells of the host's response to injury. They are the primary cell oftissue repair, and respond to IL-I by proliferation and collagen synthesis and assembly (9, 32 (16) .
We sought to investigate whether any of these well-characterized hematopoietic growth factors, or a novel growth factor, was responsible for the multilineage growth-promoting activity released by IL-la-stimulated fibroblasts.
Using poly A-enriched cellular RNA from quiescent cultures of fibroblasts, and from cells stimulated with IL-i a, we probed for the presence of known hematopoietic growth factor-specific transcripts. No (35) , these data taken together suggest that the multiple transcripts characteristic of cellular sources rich in M-CSF represent an example of alternate splicing of the primary transcription product.
Initially, we cultured quiescent fibroblasts in the presence of FCS. The conditioned medium was noted to contain low levels of CSA, and the poly A-enriched RNA contained GM-CSF-and G-CSF-specific transcripts. To reduce or eliminate the possibility that mitogens or cytokines present in the FCS might be responsible for low level stimulation of these cultures, we reduced the protein content ofthe growth medium to 2%, and substituted platelet-poor plasma for serum. Under these conditions, quiescent endothelial cells (36) and unstimulated lymphocytes (Kaushansky, K., and W. Hammond, unpublished observations), cells that can be induced to produce GM-CSF in response to mitogens and cytokines including IL-la, contain no detectable growth factor-specific mRNA. Thus, low level stimulation is not a likely explanation for our detection of CSA and GM-CSF-and G-CSF-specific transcripts in quiescent cultures of fibroblasts. When quiescent fibroblasts are stimulated with physiologic levels of IL-la, the level of CSA rises substantially, and the signals for GM-CSFand G-CSF-specific mRNA are enhanced fivefold.
Although the appearance of specific mRNA suggests the production of the corresponding polypeptide, RNA accumulation in the absence of protein secretion may occur, as has been demonstrated recently for tumor necrosis factor-a production by human monocytes (37) . To confirm the conclusions based on the Northern blot analysis, we used a number of immunologic and functional assays to detect the presence of specific hematopoietic growth factors in quiescent or IL-Iastimulated fibroblast-conditioned medium.
A sensitive radioimmunoassay detected low levels of M-CSF in both quiescent and IL-la-stimulated fibroblastconditioned medium. Using murine neutrophilic colony formation as an indication of the presence of human G-CSF, we found that the conditioned medium from quiescent fibroblasts contained low levels of G-CSF and, when fibroblasts were stimulated for 24 h with 100 pg/ml IL-la, tenfold higher levels of CSF were detected. Finally, through the use of a specific antiserum, we detected GM-CSF in concentrated IL-la-stimulated fibroblast-conditioned medium but not in medium conditioned by unstimulated fibroblasts. As the sensitivity of our Western blot system is 400 U, a low level of GM-CSF production by quiescent fibroblasts may have escaped detection.
From these findings, we conclude that fibroblasts increase the transcription, production, and release of GM-CSF and G-CSF in response to stimulation with IL-la. In addition, small amounts of M-CSF, G-CSF, and GM-CSF are constitutively produced by these cells. No multi-CSF mRNA was detected in either quiescent or IL-la-stimulated fibroblasts. Whether GM-CSF, G-CSF, and M-CSF account for all of the hematopoietic growth-promoting activity released by fibroblasts cannot be answered by these studies. Note that IL-1, at similar concentrations, stimulates the release of GM-CSF and G-CSF from endothelial cells, cells also found in the marrow microenvironment (36, 38) , and from a marrow-derived murine fibroblast/endothelial-like cell line (39) . Taken together, these data support the hypothesis that fibroblasts and endothelial cells are important components of the marrow microenvironment.
Monocytes have been shown to release numerous monokines at sites of infection, inflammation, and immunologic reaction. IL-1 can be detected in the plasma of patients with fever, inflammation, or even during physiologic stress, such as after vigorous exercise or ovulation (40, 41) . These studies have used a moderately sensitive biological assay for IL-1. We have shown that picomolar concentrations of IL-la augment the release in vitro of GM-CSF and G-CSF from candidate cells ofthe marrow microenvironment, and that IL-l is at least one of the regulatory mechanisms that signals an increase in blood cell production in response to the inflammatory state.
